Delivery Order SPE2DB25D3109-SPE2DB26FP4ND
Award Date 10/17/25
Potential Completion Date 10/20/25
Potential Value $3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,396.12 to AmerisourceBergen Drug Corp for the supply of Xcopri 50 mg tablets (30-count units). This competitively awarded, firm fixed price delivery order was issued on August 18, 2025, with an ultimate completion date of August 19, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete transaction under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Xcopri 100 mg tablets (30-count packaging) with a ceiling value of $1,178.96. This firm fixed-price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The order will be fulfilled from the...
- The Defense Logistics Agency awarded a delivery order valued at $3,660.38 to AmerisourceBergen Drug Corp for 30 tablets of Xcopri 100 mg on August 11, 2025, with an ultimate completion date of August 12, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $3,765.44 to AmerisourceBergen Drug Corp for the supply of Xcopri 150 mg tablets (30-count) with a June 3, 2025 completion date. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, was selected...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for Xcopri 150 mg tablets (30-count units) valued at $7,037.15 under a firm fixed-price contract. This is a non-set-aside award with an ultimate completion date of September 26, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. The award...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Xcopri 100 mg tablets (30-count units) with a ceiling value of $2,357.92. This firm fixed-price delivery order, which has an ultimate completion date of September 23, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation, and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Xcopri 50 mg tablets (30-count) with a ceiling value of $2,070.10. This competitive award utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract carries no set-aside designation, indicating it...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $4,330.58 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Xcopri 50 mg tablets (30-count). This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 31, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Xcopri 100 mg tablets (30-count units) with a ceiling value of $2,947.40. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The contract has an ultimate completion date of July 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,080.32 on September 2, 2025, for the supply of Xcopri 200 mg tablets (30-count units). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract was issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99...